Vimarsana
Biggest News Aggregation in the World

Page 7 - Tissue Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tissue Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tissue Diagnostics Today - Breaking & Trending Today

Robotic Prosthetics Market to Perceive Remarkable Growth of - Vimarsana News

Robotic Prosthetics Market to Perceive Remarkable Growth of

The increasing prevalence of vascular disorders, obesity, diabetes, and osteoarthritis contributed to an increase in amputation incidences, which in turn...

Global Tissue Diagnostics Market Report 2022: Growing Private Diagnostics Centers Globally Fuels Sector - Vimarsana News

Global Tissue Diagnostics Market Report 2022: Growing Private Diagnostics Centers Globally Fuels Sector

/PRNewswire/ -- The "Tissue Diagnostics Market by Product(Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology(ISH, IHC, Special...

Global Tissue Diagnostics Market Report 2022: Increasing - Vimarsana News

Global Tissue Diagnostics Market Report 2022: Increasing

Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Tissue Diagnostics Market by Product(Antibodies, Kits, Slide Staining System, Tissue Processing System),...

Cancer Tissue Diagnostics Market is Expected to Grow at - Vimarsana News

Cancer Tissue Diagnostics Market is Expected to Grow at

The United States has dominated the North American cancer tissue diagnostics market. The cancer tissue diagnostics market in Western Europe is currently...

Roche delivers good sales growth in the first nine months of 2016 » FINCHANNEL - Vimarsana News

Roche delivers good sales growth in the first nine months of 2016 » FINCHANNEL

The FINANCIAL -- Commenting on the Group’s first nine months, Roche CEO Severin Schwan said: “We had continued good sales growth in both Pharmaceuticals and Diagnostics driven by our newly launched products, and our product pipeline is developing very well. Our cancer immunotherapy medicine Tecentriq has been performing strongly since May, when it was first approved in the US for people with advanced bladder cancer, and it has just received US FDA approval for previously treated metastatic non-small cell lung cancer. Based on our performance so far, I am confident that we will meet our ful...